Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange ArcaSector Equity
Previous close
$49.66
−$0.25 · -0.50%
Sep 11, 3:59 PM ET
Regular session · ET · Market data may be delayed.
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Fund assets
47.54M USD
Expense ratio
0.65%
NAV
$50.04
Average volume
23.81K
Volume
42.75K
Day range
$49.30 – $50.72
52-week range
$23.81 – $56.18
Previous close
$49.91
Price change
1 day
-0.50%
1 month
-6.41%
3 months
+15.41%
Year to date
+28.79%
1 year
+105.89%
3 years
+132.06%
5 years
+3.91%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Sep 12, 2026.
Portfolio composition
Fund income
Dec 22, 2025
Dec 22, 2025
Dec 29, 2025
$0.6554
Annual
Dec 20, 2024
Dec 20, 2024
Dec 27, 2024
$0.2395
Annual
Dec 20, 2023
Dec 21, 2023
Dec 29, 2023
$0.0823
Annual
Dec 20, 2017
Dec 21, 2017
Dec 27, 2017
$0.2972
Annual
Dec 21, 2015
Dec 23, 2015
Dec 29, 2015
$0.147
Annual
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
